Publicação

Overcome challenges in influenza virus-like particles downstream process

Ver documento

Detalhes bibliográficos
Resumo:The development of new vaccines for influenza virus introduced a new generation of vaccines using virus-like particles (VLPs). The lack of genetic material, possibility of production on cell lines and presence of antigens with immunogenicity are the main advantages over the traditional vaccines. The development of a cost-effective downstream process while maintaining the high purity, potency and quality of VLPs is a challenge. In this thesis, several purification steps – clarification, concentration, chromatography, polishing and sterile filtration – were studied to develop a new downstream proves for influenza VLPs. In clarification step, a strategy using D0HC followed by Opticap XL SHC filters presented the best result. For concentration step, the cassette with cut-off of 300 kDa presented a higher yield on hemagglutinin recovery and the lowest process time. For chromatography step, the membrane Sartobind Q and the resin HiTrap Q HP were evaluated, concluding that resin HiTrap presented higher dynamic binding capacity and better resolution on elution. For polishing step, size-exclusion chromatography and multimodal chromatography operate in flow-through mode were compared. The last presented higher recovery yield on hemagglutinin and it was select due to the non-limitation for scale-up. Different materials were analysed for the final sterile filtration. A proof of concept run was performed were the optimized conditions and best devices were evaluated. In the end of process, it was obtained influenza VLPs with concentration and quality enough to advance for animal in vivo studies and for clinical phase I. Additionally, a new tool – magnetic sulphated cellulose particles – was evaluated with the goal to obtain purified and concentrated samples to use in characterization techniques. Overall, this thesis contributes to introduce a new tool and a novel cost-effective downstream purification process with high purity, potency and quality for the next generation of influenza vaccines - VLPs.
Autores principais:Ferreira, Hugo Miguel Lambuça
Assunto:purification process influenza vacines vírus-like particles magnetic sulphated cellulose particles processo de purificação vacinas de influenza partículas semelhantes a vírus partículas magnéticas de celulose sulfatada
Ano:2017
País:Portugal
Tipo de documento:dissertação de mestrado
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
_version_ 1868982686047010816
author Ferreira, Hugo Miguel Lambuça
author_facet Ferreira, Hugo Miguel Lambuça
author_role author
contributor_name_str_mv Lisboa, Cristina Maria da Costa Peixoto
RUN
country_str PT
creators_json_txt [{\"Person.name\":\"Ferreira, Hugo Miguel Lambuça\"}]
datacite.contributors.contributor.contributorName.fl_str_mv Lisboa, Cristina Maria da Costa Peixoto
RUN
datacite.creators.creator.creatorName.fl_str_mv Ferreira, Hugo Miguel Lambuça
datacite.date.Accepted.fl_str_mv 2017-10-20T00:00:00Z
datacite.date.available.fl_str_mv 2020-10-01T00:30:22Z
datacite.date.embargoed.fl_str_mv 2020-10-01T00:30:22Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv purification process
influenza vacines
vírus-like particles
magnetic sulphated cellulose particles
processo de purificação
vacinas de influenza
partículas semelhantes a vírus
partículas magnéticas de celulose sulfatada
datacite.titles.title.fl_str_mv Overcome challenges in influenza virus-like particles downstream process
dc.contributor.none.fl_str_mv Lisboa, Cristina Maria da Costa Peixoto
RUN
dc.creator.none.fl_str_mv Ferreira, Hugo Miguel Lambuça
dc.date.Accepted.fl_str_mv 2017-10-20T00:00:00Z
dc.date.available.fl_str_mv 2020-10-01T00:30:22Z
dc.date.embargoed.fl_str_mv 2020-10-01T00:30:22Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10362/24817
dc.language.none.fl_str_mv eng
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv purification process
influenza vacines
vírus-like particles
magnetic sulphated cellulose particles
processo de purificação
vacinas de influenza
partículas semelhantes a vírus
partículas magnéticas de celulose sulfatada
dc.title.fl_str_mv Overcome challenges in influenza virus-like particles downstream process
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_bdcc
description The development of new vaccines for influenza virus introduced a new generation of vaccines using virus-like particles (VLPs). The lack of genetic material, possibility of production on cell lines and presence of antigens with immunogenicity are the main advantages over the traditional vaccines. The development of a cost-effective downstream process while maintaining the high purity, potency and quality of VLPs is a challenge. In this thesis, several purification steps – clarification, concentration, chromatography, polishing and sterile filtration – were studied to develop a new downstream proves for influenza VLPs. In clarification step, a strategy using D0HC followed by Opticap XL SHC filters presented the best result. For concentration step, the cassette with cut-off of 300 kDa presented a higher yield on hemagglutinin recovery and the lowest process time. For chromatography step, the membrane Sartobind Q and the resin HiTrap Q HP were evaluated, concluding that resin HiTrap presented higher dynamic binding capacity and better resolution on elution. For polishing step, size-exclusion chromatography and multimodal chromatography operate in flow-through mode were compared. The last presented higher recovery yield on hemagglutinin and it was select due to the non-limitation for scale-up. Different materials were analysed for the final sterile filtration. A proof of concept run was performed were the optimized conditions and best devices were evaluated. In the end of process, it was obtained influenza VLPs with concentration and quality enough to advance for animal in vivo studies and for clinical phase I. Additionally, a new tool – magnetic sulphated cellulose particles – was evaluated with the goal to obtain purified and concentrated samples to use in characterization techniques. Overall, this thesis contributes to introduce a new tool and a novel cost-effective downstream purification process with high purity, potency and quality for the next generation of influenza vaccines - VLPs.
dirty 0
eu_rights_str_mv openAccess
format masterThesis
fulltext.url.fl_str_mv https://run.unl.pt/bitstreams/1cde794a-ec1e-4ded-83bd-df0b26e0ceb2/download
id run_7d1cd433aeb6191ef5bc58f6740efd89
identifier.url.fl_str_mv http://hdl.handle.net/10362/24817
inst_facet_str urn:organizationAcronym:unl{{{_:::_}}}Universidade Nova de Lisboa
instacron_str unl
institution Universidade Nova de Lisboa
instname_str Universidade Nova de Lisboa
language eng
network_acronym_str run
network_name_str Repositório Institucional da UNL
oai_identifier_str oai:run.unl.pt:10362/24817
organization_str_mv urn:organizationAcronym:unl
person_str_mv Ferreira, Hugo Miguel Lambuça
publishDate 2017
repo_facet_str urn:repositoryAcronym:run{{{_:::_}}}Repositório Institucional da UNL
reponame_str Repositório Institucional da UNL
repository_id_str urn:repositoryAcronym:run
service_str_mv urn:repositoryAcronym:run
spelling engpt_PTThe development of new vaccines for influenza virus introduced a new generation of vaccines using virus-like particles (VLPs). The lack of genetic material, possibility of production on cell lines and presence of antigens with immunogenicity are the main advantages over the traditional vaccines. The development of a cost-effective downstream process while maintaining the high purity, potency and quality of VLPs is a challenge. In this thesis, several purification steps – clarification, concentration, chromatography, polishing and sterile filtration – were studied to develop a new downstream proves for influenza VLPs. In clarification step, a strategy using D0HC followed by Opticap XL SHC filters presented the best result. For concentration step, the cassette with cut-off of 300 kDa presented a higher yield on hemagglutinin recovery and the lowest process time. For chromatography step, the membrane Sartobind Q and the resin HiTrap Q HP were evaluated, concluding that resin HiTrap presented higher dynamic binding capacity and better resolution on elution. For polishing step, size-exclusion chromatography and multimodal chromatography operate in flow-through mode were compared. The last presented higher recovery yield on hemagglutinin and it was select due to the non-limitation for scale-up. Different materials were analysed for the final sterile filtration. A proof of concept run was performed were the optimized conditions and best devices were evaluated. In the end of process, it was obtained influenza VLPs with concentration and quality enough to advance for animal in vivo studies and for clinical phase I. Additionally, a new tool – magnetic sulphated cellulose particles – was evaluated with the goal to obtain purified and concentrated samples to use in characterization techniques. Overall, this thesis contributes to introduce a new tool and a novel cost-effective downstream purification process with high purity, potency and quality for the next generation of influenza vaccines - VLPs.application/pdfpt_PTOvercome challenges in influenza virus-like particles downstream processFerreira, Hugo Miguel LambuçaLisboa, Cristina Maria da Costa PeixotoHostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.pt2020-10-01T00:30:22Z2017-10-202017-10-20T00:00:00ZHandlehttp://hdl.handle.net/10362/24817http://purl.org/coar/access_right/c_abf2open accesspurification processinfluenza vacinesvírus-like particlesmagnetic sulphated cellulose particlesprocesso de purificaçãovacinas de influenzapartículas semelhantes a víruspartículas magnéticas de celulose sulfatada2224912 bytesliteraturehttp://purl.org/coar/resource_type/c_bdccmaster thesishttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://run.unl.pt/bitstreams/1cde794a-ec1e-4ded-83bd-df0b26e0ceb2/download
spellingShingle Overcome challenges in influenza virus-like particles downstream process
Ferreira, Hugo Miguel Lambuça
purification process
influenza vacines
vírus-like particles
magnetic sulphated cellulose particles
processo de purificação
vacinas de influenza
partículas semelhantes a vírus
partículas magnéticas de celulose sulfatada
status SINGLETON
subject.fl_str_mv purification process
influenza vacines
vírus-like particles
magnetic sulphated cellulose particles
processo de purificação
vacinas de influenza
partículas semelhantes a vírus
partículas magnéticas de celulose sulfatada
title Overcome challenges in influenza virus-like particles downstream process
title_full Overcome challenges in influenza virus-like particles downstream process
title_fullStr Overcome challenges in influenza virus-like particles downstream process
title_full_unstemmed Overcome challenges in influenza virus-like particles downstream process
title_short Overcome challenges in influenza virus-like particles downstream process
title_sort Overcome challenges in influenza virus-like particles downstream process
topic purification process
influenza vacines
vírus-like particles
magnetic sulphated cellulose particles
processo de purificação
vacinas de influenza
partículas semelhantes a vírus
partículas magnéticas de celulose sulfatada
topic_facet purification process
influenza vacines
vírus-like particles
magnetic sulphated cellulose particles
processo de purificação
vacinas de influenza
partículas semelhantes a vírus
partículas magnéticas de celulose sulfatada
url http://hdl.handle.net/10362/24817
visible 1